COMMUNIQUÉS West-GlobeNewswire

NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
13/03/2024
WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in [...]
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
13/03/2024
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed ® at 1PM ET -- ATLANTA, March [...]
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
13/03/2024
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA- [...]
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
13/03/2024
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present [...]
Cerevance Announces Presentation at Alzheimer’s Research UK Conference
13/03/2024
BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced plans to present a poster at the upcoming [...]
Safety Shot Taps Music and Film Industry Veteran Jordan Schur as New President and Company Board Member
13/03/2024
With tremendous success throughout a storied career in the music and film industries, Schur aims to significantly boost brand awareness for Safety Shot. JUPITER, FL, March 13, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc [...]
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
13/03/2024
ZUG, Switzerland and BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]
Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
13/03/2024
Event hosted by the U.S. Army Medical Research and Development Command’s (USAMRDC) Combat Casualty Care Research Program (CCCRP) Neurotrauma Portfolio and the Biomedical Advanced Research and Development Authority ( [...]
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland
13/03/2024
COPENHAGEN, Denmark, March 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS ® (MVA-BN) for active immunization against disease [...]
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
13/03/2024
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of [...]
Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
13/03/2024
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of [...]
Liberation Labs Taps Biotech Biomanufacturing Veteran Rhys Dale to Assist with Development & Operations of Flagship Facility
13/03/2024
Dale has more than 20 years’ experience in developing and operating biomanufacturing facilities in the U.S. and Internationally RICHMOND, Ind., March 13, 2024 (GLOBE NEWSWIRE) -- Liberation Labs has appointed Rhys Dale [...]
Annual General Meeting 2024 – GN Store Nord A/S
13/03/2024
Today, GN Store Nord A/S held its Annual General Meeting. The Annual General Meeting was held in accordance with the agenda announced on February 19, 2024, as set out below. The report by the Board of Directors was [...]
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
13/03/2024
DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410
13/03/2024
MALVERN, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]
3Daughters Announces Three New Appointments to Board of Directors
13/03/2024
Board will help advance the mission and support development of our game-changing IUD for contraception (3D-001) MANSFIELD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- 3Daughters , a clinical development company fueling [...]
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
13/03/2024
New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company’s booth generated a record-high number of sales leads and [...]
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
13/03/2024
Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8 ® for the treatment of ALS with the objective of submitting an NDA in 2024 Released long-term data from the open-label extension of the [...]
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
13/03/2024
Preclinical research published in Vaccines demonstrates Infectimune ® significantly improved quantity and quality of potent multifunctional CD4 T cells compared to vaccine adjuvants Patent for composition of matter and [...]

Pages